Daniel Schmolze

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 9

Top Venues

NPJ precision oncology

Cancer immunology research

JCO precision oncology

NPJ breast cancer

City of Hope Comprehensive Cancer Center

Rochester Institute of Technology (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

City of Hope Comprehensive Cancer Center Sep 01 2016

United States

Assistant Clinical Professor :: Pathology

Jackson Laboratory

United States

Software Engineer

Education History

Rochester Institute of Technology Sep 01 2000 - May 30 2002

United States

BSC :: Information Technology

Publications

Eliza R Bacon, Kena Ihle, Weihua Guo, Colt A Egelston, Diana L Simons, Christina Wei, Lusine Tumyan, Daniel Schmolze, Peter P Lee, James R Waisman
Tumor heterogeneity and clinically invisible micrometastases in metastatic breast cancer-a call for enhanced surveillance strategies. NPJ precision oncology 8 (1) (2024)
Colt A Egelston, Weihua Guo, Diana L Simons, Jian Ye, Christian Avalos, Shawn T Solomon, Mary Nwangwu, Michael S Nelson, Jiayi Tan, Eliza R Bacon, Kena Ihle, Daniel Schmolze, Lusine Tumyan, James R Waisman, Peter P Lee
Organ-specific immune setpoints underlie divergent immune profiles across metastatic sites in breast cancer. Cancer immunology research (2024)
Eliza R Bacon, Kena Ihle, Weihua Guo, Colt A Egelston, Diana L Simons, Christina Wei, Lusine Tumyan, Daniel Schmolze, Peter P Lee, James R Waisman
Tumor heterogeneity and clinically invisible micrometastases in metastatic breast cancer-a call for enhanced surveillance strategies. NPJ precision oncology 8 (1) (2024)
Colt A Egelston, Weihua Guo, Diana L Simons, Jian Ye, Christian Avalos, Shawn T Solomon, Mary Nwangwu, Michael S Nelson, Jiayi Tan, Eliza R Bacon, Kena Ihle, Daniel Schmolze, Lusine Tumyan, James R Waisman, Peter P Lee
Organ-specific immune setpoints underlie divergent immune profiles across metastatic sites in breast cancer. Cancer immunology research (2024)
Yuan Chun Ding, Hanbing Song, Aaron W Adamson, Daniel Schmolze, Donglei Hu, Scott Huntsman, Linda Steele, Carmina S Patrick, Shu Tao, Natalie Hernandez, Charleen D Adams, Laura Fejerman, Kevin Gardner, Anna Maria Napoles, Eliseo J Pérez-Stable, Jeffrey N Weitzel, Henrik Bengtsson, Franklin W Huang, Susan L Neuhausen, Elad Ziv
Profiling the somatic mutational landscape of breast tumors from Hispanic/Latina women reveals conserved and unique characteristics. Cancer research (2023)
Thanh H Dellinger, Ernest S Han, Mustafa Raoof, Byrne Lee, Xiwei Wu, Hyejin Cho, Ting-Fang He, Peter P Lee, Marianne Razavi, Winnie S Liang, Daniel Schmolze, Saul J Priceman, Stephen Lee, Wei-Chien Lin, Jeff F Lin, Mehdi Kebria, Amy Hakim, Nora Ruel, Daphne B Stewart, Edward W Wang, Benjamin I Paz, Mark T Wakabayashi, Mihaela C Cristea, Lorna Rodriguez-Rodriguez
Hyperthermic Intraperitoneal Chemotherapy-Induced Molecular Changes in Humans Validate Preclinical Data in Ovarian Cancer. JCO precision oncology 6 (2022)
Juliana C Wortman, Ting-Fang He, Shawn T Solomon, Robert Z Zhang, Anthony Rosario, Roger Wang, Travis Y Tu, Daniel Schmolze, Yuan Yuan, Susan E Yost, Xuefei Li, Herbert Levine, Gurinder Atwal, Peter P Lee, Clare C Yu
Spatial distribution of B cells and lymphocyte clusters as a predictor of triple-negative breast cancer outcome. NPJ breast cancer 7 (1) (2021)
Christina H Wei, Robert West, Daniel Schmolze, Sophia K Apple
Clinical vs genomic risks in breast cancer in 2019: Breast pathologist's appellate review of the controversial results from TAILORx trial. The breast journal 26 (7) (2020)
Lei Wang, Diana L Simons, Xuyang Lu, Travis Y Tu, Shawn Solomon, Roger Wang, Anthony Rosario, Christian Avalos, Daniel Schmolze, John Yim, James Waisman, Peter P Lee
Connecting blood and intratumoral Treg cell activity in predicting future relapse in breast cancer. Nature immunology 20 (9) (2019)

Daniel Schmolze.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Daniel Schmolze